These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 15679785)
21. P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors. Langner C; Ratschek M; Tsybrovskyy O; Schips L; Zigeuner R J Histochem Cytochem; 2003 Aug; 51(8):1097-9. PubMed ID: 12871991 [TBL] [Abstract][Full Text] [Related]
22. CD117+ small cell lung cancer lacks the asp 816-->val point mutation in exon 17. Mojica WD; Saxena R; Starostik P; Cheney RT Histopathology; 2005 Nov; 47(5):517-22. PubMed ID: 16242000 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate. Hofmann UB; Kauczok-Vetter CS; Houben R; Becker JC Clin Cancer Res; 2009 Jan; 15(1):324-9. PubMed ID: 19118061 [TBL] [Abstract][Full Text] [Related]
24. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449 [TBL] [Abstract][Full Text] [Related]
25. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. Nakanishi K; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Matsuyama S; Matsuyama T; Kawai T Clin Cancer Res; 2005 Apr; 11(7):2583-90. PubMed ID: 15814637 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma. Reed J; Ouban A; Schickor FK; Muraca P; Yeatman T; Coppola D Clin Colorectal Cancer; 2002 Aug; 2(2):119-22. PubMed ID: 12453327 [TBL] [Abstract][Full Text] [Related]
27. Cajal-like cells in the human upper urinary tract. Metzger R; Schuster T; Till H; Stehr M; Franke FE; Dietz HG J Urol; 2004 Aug; 172(2):769-72. PubMed ID: 15247779 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma. Ahmed EA; Youssif ME J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563 [TBL] [Abstract][Full Text] [Related]
29. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization. Wang X; MacLennan GT; Zhang S; Montironi R; Lopez-Beltran A; Tan PH; Foster S; Baldridge LA; Cheng L Hum Pathol; 2009 Feb; 40(2):211-7. PubMed ID: 18799188 [TBL] [Abstract][Full Text] [Related]
30. Rare expression of KIT and absence of KIT mutations in high grade renal cell carcinoma. Sengupta S; Cheville JC; Corless CL; Lohse CM; Heinrich MC; Kwon ED; Zincke H; Blute ML; Leibovich BC J Urol; 2006 Jan; 175(1):53-6. PubMed ID: 16406868 [TBL] [Abstract][Full Text] [Related]
31. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Li G; Barthelemy A; Feng G; Gentil-Perret A; Peoc'h M; Genin C; Tostain J Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501 [TBL] [Abstract][Full Text] [Related]
32. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate. Swick BL; Ravdel L; Fitzpatrick JE; Robinson WA J Cutan Pathol; 2007 Apr; 34(4):324-9. PubMed ID: 17381803 [TBL] [Abstract][Full Text] [Related]
33. Expression of S-100 protein in renal cell neoplasms. Lin F; Yang W; Betten M; Teh BT; Yang XJ; Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922 [TBL] [Abstract][Full Text] [Related]
34. KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas. Pan CC; Chen PC; Chiang H J Pathol; 2004 Mar; 202(3):375-81. PubMed ID: 14991904 [TBL] [Abstract][Full Text] [Related]
35. Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma. Schips L; Zigeuner R; Ratschek M; Rehak P; Rüschoff J; Langner C Am J Clin Pathol; 2004 Dec; 122(6):931-7. PubMed ID: 15539386 [TBL] [Abstract][Full Text] [Related]
36. Rare expression of KIT (CD117) in lymphomas: a tissue microarray study of 1166 cases. Zimpfer A; Went P; Tzankov A; Pehrs AC; Lugli A; Maurer R; Terracciano L; Pileri S; Dirnhofer S Histopathology; 2004 Oct; 45(4):398-404. PubMed ID: 15469479 [TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical characterization of 13 canine renal cell carcinomas. Gil da Costa RM; Oliveira JP; Saraiva AL; Seixas F; Faria F; Gärtner F; Pires MA; Lopes C Vet Pathol; 2011 Mar; 48(2):427-32. PubMed ID: 20861495 [TBL] [Abstract][Full Text] [Related]
38. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604 [TBL] [Abstract][Full Text] [Related]
39. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall. Pauwels P; Debiec-Rychter M; Stul M; De Wever I; Van Oosterom AT; Sciot R Histopathology; 2005 Jul; 47(1):41-7. PubMed ID: 15982322 [TBL] [Abstract][Full Text] [Related]
40. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof]. Zhou JT; Cai ZM; Li NC; Na YQ Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]